Lewin A, Lavon H
Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical School, Jerusalem, Israel.
Mol Aspects Med. 1997;18 Suppl:S213-9. doi: 10.1016/s0098-2997(97)00036-8.
In sperm cells, the majority of coenzyme Q10 (CoQ10) an energy promoting agent and antioxidant, is concentrated in the mitochondria of the midpiece, so that the energy for movement and all other energy-dependent processes in the sperm cell also depend on the availability of CoQ10. The reduced form of CoQ10-ubiquinol also acts as an antioxidant, preventing lipid peroxidation in sperm membranes. The objective of the study was to evaluate the effect of CoQ10 on sperm motility in vitro, after incubation with 38 samples of asthenospermic and normal motility sperm, and to evaluate the effect of CoQ10 administration in vivo in 17 patients with low fertilization rates after in vitro fertilization with intracytoplasmic sperm injection (ICSI) for male factor infertility. All 38 sperm samples from patients registered in our infertility clinic had normal concentrations and morphology. Of these, 16 patients had normal motility (mean 47.5%) and 22 patients were asthenospermic (mean motility 19.1%). Sperm samples were divided into four equal parts and incubated for 24 h in: HAM's medium alone, in HAM's medium with 1% DMSO and HAM's with 5 microM or 50 microM CoQ10. While no significant change in motility after incubation was observed in the samples with initial normal motility, a significant increase in motility was observed in the 50 microM CoQ10 subgroup of sperm from asthenospermic men, with a motility rate of 35.7 +/- 19.5%, as compared to 19.1 +/- 9.3% in the controls (P < 0.05). The 17 patients with low fertilization rates after ICSI were treated with oral CoQ10, 60 mg/day, for a mean of 103 days before the next ICSI treatment. No significant change was noted in most sperm parameters, but a significant improvement was noted in fertilization rates, from a mean of 10.3 +/- 10.5% in their previous cycles, to 26.3 +/- 22.8% after CoQ10 (P < 0.05). In conclusion, the administration of CoQ10 may result in improvement in sperm functions in selective patients. Further investigation into the mechanisms related to these effects is needed.
在精子细胞中,大部分辅酶Q10(CoQ10),一种能量促进剂和抗氧化剂,集中在中段的线粒体中,因此精子细胞运动所需的能量以及所有其他依赖能量的过程也取决于CoQ10的可用性。还原型CoQ10 - 泛醇也作为抗氧化剂,防止精子膜中的脂质过氧化。该研究的目的是评估CoQ10对体外精子活力的影响,方法是将其与38份弱精子症和正常活力精子样本一起孵育,并评估CoQ10对17例因男性因素不育而接受卵胞浆内单精子注射(ICSI)体外受精后受精率低的患者进行体内给药的效果。我们不育诊所登记的所有38例患者的精子样本浓度和形态均正常。其中,16例患者精子活力正常(平均47.5%),22例患者为弱精子症(平均活力19.1%)。精子样本被分成四等份,分别在以下条件下孵育24小时:单独的哈姆氏培养基、含1%二甲基亚砜的哈姆氏培养基以及含5微摩尔或50微摩尔CoQ10的哈姆氏培养基。虽然初始活力正常的样本在孵育后活力没有显著变化,但弱精子症男性精子的50微摩尔CoQ10亚组中观察到活力显著增加,活力率为35.7±19.5%,而对照组为19.1±9.3%(P<0.05)。17例ICSI后受精率低的患者在下次ICSI治疗前平均103天接受口服CoQ10治疗,剂量为60毫克/天。大多数精子参数没有显著变化,但受精率有显著改善,从之前周期的平均10.3±10.5%提高到CoQ10治疗后的26.3±22.8%(P<0.05)。总之,CoQ10给药可能会使部分患者的精子功能得到改善。需要进一步研究与这些作用相关的机制。